找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊Expert Review of Neurotherapeutics 2024/2025影响因子:3.494 (EXPERT REV NEUROTHER) (1473-7175). (PHARMACOLOGY & PHARMA  ...234
Total Citations:5307; 2023 JIF:3.494; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.611; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.3; Immediacy Index:0.8; Immediacy Index-dealt:0.825; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:28; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.004; Normalized Eigenfactor:0.881; Article Influence Score:1.204; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:108; % of Articles in Citable items:0.2593; Cited Half-Life:8.2; Citing Half-Life:7; % of OA Gold:0.1466; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9
投票 SCIE期刊NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.611 (NEUROPSYCHOPHARMACOL) (0893-133X). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:28267; 2023 JIF:6.611; JIFRank: 20/354 ; Rank-JIF: 20; Number-of-JIF:354; 5 Year JIF:7.387; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.5; Immediacy Index:1.2; Immediacy Index-dealt:1.252; 2023 JCI:1.6; JCI Rank: 24/354 ; Total Articles:152; JCI Quartile:Q1; JCI Percentile:93.36; Eigenfactor:0.029; Normalized Eigenfactor:6.263; Article Influence Score:2.71; JIF Percentile:94.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:175; % of Articles in Citable items:0.8686; Cited Half-Life:8.6; Citing Half-Life:8.2; % of OA Gold:0.3581; Publisher name:GALENOS PUBL HOUSE; Publisher address:Kacamak Sokak 21/1, ISTANBUL, Turkiye,
投票 SCIE期刊BioImpacts 2024/2025影响因子:2.251 (BIOIMPACTS) (2228-5652). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index  ...234
Total Citations:1209; 2023 JIF:2.251; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:2.909; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.1; Immediacy Index:0.5; Immediacy Index-dealt:0.527; 2023 JCI:0.75; JCI Rank: 144/354 ; Total Articles:41; JCI Quartile:Q2; JCI Percentile:59.46; Eigenfactor:0.001; Normalized Eigenfactor:0.167; Article Influence Score:0.464; JIF Percentile:42.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:42; % of Articles in Citable items:0.9762; Cited Half-Life:6; Citing Half-Life:7; % of OA Gold:0.9128; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊DRUGS 2024/2025影响因子:13.121 (DRUGS) (0012-6667). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Expanded  ...234
Total Citations:19942; 2023 JIF:13.121; JIFRank: 7/354 ; Rank-JIF: 7; Number-of-JIF:354; 5 Year JIF:11.452; 5 Year JIF Quartile:Q1; JIF Without Self Cites:12.9; Immediacy Index:2.5; Immediacy Index-dealt:2.585; 2023 JCI:2.99; JCI Rank: 3/354 ; Total Articles:76; JCI Quartile:Q1; JCI Percentile:99.53; Eigenfactor:0.019; Normalized Eigenfactor:4.104; Article Influence Score:2.92; JIF Percentile:99.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:127; % of Articles in Citable items:0.5984; Cited Half-Life:6.7; Citing Half-Life:5.4; % of OA Gold:0.2944; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United
投票 SCIE期刊AAPS Journal 2024/2025影响因子:5.126 (AAPS J) (1550-7416). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Ex  ...234
Total Citations:7342; 2023 JIF:5.126; JIFRank: 43/354 ; Rank-JIF: 43; Number-of-JIF:354; 5 Year JIF:4.157; 5 Year JIF Quartile:Q2; JIF Without Self Cites:4.8; Immediacy Index:0.7; Immediacy Index-dealt:0.715; 2023 JCI:0.98; JCI Rank: 84/354 ; Total Articles:72; JCI Quartile:Q1; JCI Percentile:76.41; Eigenfactor:0.004; Normalized Eigenfactor:NULL; Article Influence Score:NULL; JIF Percentile:88; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:86; % of Articles in Citable items:0.8372; Cited Half-Life:8.4; Citing Half-Life:6.2; % of OA Gold:0.3333; Publisher name:AMER ASSOC PETROLEUM GEOLOGIST; Publisher address:1444 S BOULDER AVE, PO BOX 979,
投票 SCIE期刊JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 2024/2025影响因子:2.298 (J PHARMACOKINET PHAR) (1567-567X). (PHARMAC  ...234
Total Citations:1728; 2023 JIF:2.298; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:2.435; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.3; Immediacy Index-dealt:0.305; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:37; JCI Quartile:Q2; JCI Percentile:50.14; Eigenfactor:0.001; Normalized Eigenfactor:0.292; Article Influence Score:0.644; JIF Percentile:42.5; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:45; % of Articles in Citable items:0.8222; Cited Half-Life:8.6; Citing Half-Life:7.8; % of OA Gold:0.3889; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unit
投票 SCIE期刊Therapeutic Advances in Drug Safety 2024/2025影响因子:3.459 (THER ADV DRUG SAF) (2042-0986). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:1536; 2023 JIF:3.459; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.144; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.6; Immediacy Index-dealt:0.654; 2023 JCI:0.72; JCI Rank: 160/354 ; Total Articles:20; JCI Quartile:Q2; JCI Percentile:54.94; Eigenfactor:0.002; Normalized Eigenfactor:0.392; Article Influence Score:1.134; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:26; % of Articles in Citable items:0.7692; Cited Half-Life:5.9; Citing Half-Life:5.7; % of OA Gold:0.9438; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y
投票 SCIE期刊Current Topics in Nutraceutical Research 2024/2025影响因子:0.408 (CURR TOP NUTRACEUT R) (1540-7535). (PHARMACOLOGY &  ...234
Total Citations:257; 2023 JIF:0.408; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.422; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:<0.1; Immediacy Index-dealt:0.078; 2023 JCI:0.13; JCI Rank: 332/354 ; Total Articles:75; JCI Quartile:Q4; JCI Percentile:6.36; Eigenfactor:0; Normalized Eigenfactor:0.032; Article Influence Score:0.049; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:82; % of Articles in Citable items:0.9146; Cited Half-Life:4.6; Citing Half-Life:4.9; % of OA Gold:0; Publisher name:ROYAL SOC CHEMISTRY; Publisher address:THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, C
投票 SCIE期刊Journal of Managed Care & Specialty Pharmacy 2024/2025影响因子:2.341 (J MANAG CARE SPEC PH) (2376-0540). (PHARMACOLOG  ...234
Total Citations:2628; 2023 JIF:2.341; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.384; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.6; Immediacy Index-dealt:0.611; 2023 JCI:0.66; JCI Rank: 175/354 ; Total Articles:120; JCI Quartile:Q2; JCI Percentile:50.71; Eigenfactor:0.005; Normalized Eigenfactor:1.025; Article Influence Score:0.757; JIF Percentile:43.9; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:128; % of Articles in Citable items:0.9375; Cited Half-Life:4.6; Citing Half-Life:6.3; % of OA Gold:0.0071; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LO
投票 SCIE期刊Annual Review of Pharmacology and Toxicology 2024/2025影响因子:11.236 (ANNU REV PHARMACOL) (0362-1642). (PHARMACOLOGY  ...234
Total Citations:8212; 2023 JIF:11.236; JIFRank: 9/354 ; Rank-JIF: 9; Number-of-JIF:354; 5 Year JIF:12.921; 5 Year JIF Quartile:Q1; JIF Without Self Cites:11.2; Immediacy Index:7.4; Immediacy Index-dealt:7.461; 2023 JCI:2.12; JCI Rank: 11/354 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:96.7; Eigenfactor:0.005; Normalized Eigenfactor:1.129; Article Influence Score:3.823; JIF Percentile:98.6; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:31; % of Articles in Citable items:0; Cited Half-Life:10.8; Citing Half-Life:14.6; % of OA Gold:0.3366; Publisher name:AMER PUBLIC HEALTH ASSOC INC; Publisher address:800 I STREET, NW, WASHINGTON, USA,
投票 SCIE期刊PHARMACEUTICAL STATISTICS 2024/2025影响因子:1.317 (PHARM STAT) (1539-1604). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:1986; 2023 JIF:1.317; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.572; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.2; Immediacy Index-dealt:0.237; 2023 JCI:0.54; JCI Rank: 223/354 ; Total Articles:63; JCI Quartile:Q2; JCI Percentile:52.68; Eigenfactor:0.003; Normalized Eigenfactor:0.664; Article Influence Score:0.942; JIF Percentile:61.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:63; % of Articles in Citable items:1; Cited Half-Life:11.1; Citing Half-Life:9.6; % of OA Gold:0.1441; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊PHYTOMEDICINE 2024/2025影响因子:6.707 (PHYTOMEDICINE) (0944-7113). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation  ...234
Total Citations:22347; 2023 JIF:6.707; JIFRank: 19/354 ; Rank-JIF: 19; Number-of-JIF:354; 5 Year JIF:6.295; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.4; Immediacy Index:1.5; Immediacy Index-dealt:1.512; 2023 JCI:2.03; JCI Rank: 14/354 ; Total Articles:600; JCI Quartile:Q1; JCI Percentile:98.84; Eigenfactor:0.017; Normalized Eigenfactor:3.626; Article Influence Score:0.948; JIF Percentile:96.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:660; % of Articles in Citable items:0.9091; Cited Half-Life:4.3; Citing Half-Life:5.2; % of OA Gold:0.1406; Publisher name:ANCIENT MONUMENTS SOC; Publisher address:ST ANNS VESTRY HALL, 2 CHURCH ENTR
投票 SCIE期刊PEPTIDES 2024/2025影响因子:2.811 (PEPTIDES) (0196-9781). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Expa  ...234
Total Citations:9030; 2023 JIF:2.811; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:2.974; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:1; Immediacy Index-dealt:1.154; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:87; JCI Quartile:Q3; JCI Percentile:43.28; Eigenfactor:0.004; Normalized Eigenfactor:0.85; Article Influence Score:0.67; JIF Percentile:48.1; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:91; % of Articles in Citable items:0.956; Cited Half-Life:11.9; Citing Half-Life:6.4; % of OA Gold:0.2776; Publisher name:SPRINGER/PLENUM PUBLISHERS; Publisher address:233 SPRING ST, NEW YORK, USA, NY,
投票 SCIE期刊NATURE REVIEWS DRUG DISCOVERY 2024/2025影响因子:122.748 (NAT REV DRUG DISCOV) (1474-1776). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:48152; 2023 JIF:122.748; JIFRank: 1/354 ; Rank-JIF: 1; Number-of-JIF:354; 5 Year JIF:114.926; 5 Year JIF Quartile:Q1; JIF Without Self Cites:122.2; Immediacy Index:14.2; Immediacy Index-dealt:14.251; 2023 JCI:13.41; JCI Rank: 1/354 ; Total Articles:7; JCI Quartile:Q1; JCI Percentile:99.86; Eigenfactor:0.058; Normalized Eigenfactor:12.658; Article Influence Score:36.972; JIF Percentile:99.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:37; % of Articles in Citable items:0.1892; Cited Half-Life:6.6; Citing Half-Life:4.9; % of OA Gold:0.0991; Publisher name:AMER CHEMICAL SOC; Publisher address:1155 16TH ST, NW, WASHINGTON, USA
投票 SCIE期刊PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY 2024/2025影响因子:2.684 (PHARM DEV TECHNOL) (1083-7450). (PHARMACOLOGY & PH  ...234
Total Citations:3871; 2023 JIF:2.684; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:3.161; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.638; 2023 JCI:0.83; JCI Rank: 122/354 ; Total Articles:71; JCI Quartile:Q2; JCI Percentile:65.68; Eigenfactor:0.002; Normalized Eigenfactor:0.413; Article Influence Score:0.417; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:84; % of Articles in Citable items:0.8452; Cited Half-Life:6.7; Citing Half-Life:7.1; % of OA Gold:0.0568; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, US
投票 SCIE期刊DRUG METABOLISM AND DISPOSITION 2024/2025影响因子:4.454 (DRUG METAB DISPOS) (0090-9556). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:12682; 2023 JIF:4.454; JIFRank: 65/354 ; Rank-JIF: 65; Number-of-JIF:354; 5 Year JIF:3.758; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.7; Immediacy Index:1.4; Immediacy Index-dealt:1.453; 2023 JCI:1.13; JCI Rank: 65/354 ; Total Articles:121; JCI Quartile:Q1; JCI Percentile:81.78; Eigenfactor:0.005; Normalized Eigenfactor:1.095; Article Influence Score:0.842; JIF Percentile:81.8; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:157; % of Articles in Citable items:0.7707; Cited Half-Life:12.3; Citing Half-Life:10; % of OA Gold:0.1886; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAM
投票 SCIE期刊JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 2024/2025影响因子:3.144 (J PHARMACOL EXP THER) (0022-3565). (PH  ...234
Total Citations:21598; 2023 JIF:3.144; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.346; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:2.4; Immediacy Index-dealt:2.464; 2023 JCI:1; JCI Rank: 81/354 ; Total Articles:102; JCI Quartile:Q1; JCI Percentile:77.26; Eigenfactor:0.006; Normalized Eigenfactor:1.326; Article Influence Score:0.824; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:121; % of Articles in Citable items:0.843; Cited Half-Life:16.9; Citing Half-Life:8.2; % of OA Gold:0.2568; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unite
投票 SCIE期刊ALCOHOL 2024/2025影响因子:2.536 (ALCOHOL) (0741-8329). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Expand  ...234
Total Citations:2973; 2023 JIF:2.536; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.224; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.4; Immediacy Index:1.3; Immediacy Index-dealt:1.355; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:71; JCI Quartile:Q3; JCI Percentile:40.91; Eigenfactor:0.002; Normalized Eigenfactor:0.453; Article Influence Score:0.612; JIF Percentile:57.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:72; % of Articles in Citable items:0.9861; Cited Half-Life:9.2; Citing Half-Life:9.6; % of OA Gold:0.2973; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 SCIE期刊DISSOLUTION TECHNOLOGIES 2024/2025影响因子:1.195 (DISSOLUT TECHNOL) (1521-298X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sci  ...234
Total Citations:480; 2023 JIF:1.195; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.116; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.2; Immediacy Index-dealt:0.227; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:25; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0; Normalized Eigenfactor:0.028; Article Influence Score:0.141; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:26; % of Articles in Citable items:0.9615; Cited Half-Life:12; Citing Half-Life:10.5; % of OA Gold:0; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST, PHI
投票 SCIE期刊BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2024/2025影响因子:3.128 (BRIT J CLIN PHARMACO) (0306-5251). (PHARMACOLOGY &  ...234
Total Citations:17303; 2023 JIF:3.128; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.744; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.4; Immediacy Index-dealt:0.493; 2023 JCI:0.81; JCI Rank: 124/354 ; Total Articles:245; JCI Quartile:Q2; JCI Percentile:65.11; Eigenfactor:0.016; Normalized Eigenfactor:3.428; Article Influence Score:1.109; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:292; % of Articles in Citable items:0.839; Cited Half-Life:8.5; Citing Half-Life:7.6; % of OA Gold:0.4597; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 07:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块